Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Maia

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|August 16, 2025
Bringing an immuno-PCR-based pharmacodynamic biomarker assay for reduced human IL-33 in serum, plasma, and aqueous humor into the clinicJohn Hok Nin Lowe, Trung Nguy, Randall Dere, et al.
The AAPS Journal|June 20, 2014
Lower exposure and faster clearance of bevacizumab in gastric cancer and the impact of patient variables: analysis of individual data from AVAGAST phase III trialKelong Han, Jin Jin, Mauricio Maia, et al.
Japanese Journal of Ophthalmology|April 1, 2009
Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the Pan-American Collaborative Retina Study Group (PACORES) at the 12-month follow-upLihteh Wu, J Fernando Arevalo, Mauricio Maia, et al.
Bioanalysis|August 27, 2014
A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical studyKeyang Xu, Luna Liu, Mauricio Maia, et al.
Journal of Immunological Methods|May 18, 2018
Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serumJohn Lowe, Eric Wakshull, Theresa Shek, et al.
Toxicologic Pathology|December 10, 2020
Nonclinical Safety Assessment of FHTR2163, An Antigen-Binding Fragment Against HTRA1 for the Treatment of Geographic AtrophyEdward Dere, Susan Crowell, Mauricio Maia, et al.
Retinal Cases & Brief Reports|June 25, 2021
UNDERSTANDING THE MYSTERY MACULA, A SUPPLEMENT OF RETINAL CASES AND BRIEF REPORTSMauricio Maia, Raul N Vianna, Marcio B Nehemy, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
ReplyNadyr A Damasceno, Soraya A Horowitz, Mauricio Maia, et al.
Acta Ophthalmologica|November 13, 2007
Thermal damage to a light probe using a xenon light sourceFernando M Penha, Mauricio Maia, Michel E Farah, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 15, 2025
The use of amniotic membrane or inverted internal limiting membrane flap for large or refractory macular holes: a prospective, comparative study using microperimetryAnna Carolina Carvalho Araujo, Arnaldo F Bordon, Vinicius Falcão, et al.
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Journal of Pharmaceutical and Biomedical Analysis|August 16, 2025
Bringing an immuno-PCR-based pharmacodynamic biomarker assay for reduced human IL-33 in serum, plasma, and aqueous humor into the clinicJohn Hok Nin Lowe, Trung Nguy, Randall Dere, et al.
The AAPS Journal|June 20, 2014
Lower exposure and faster clearance of bevacizumab in gastric cancer and the impact of patient variables: analysis of individual data from AVAGAST phase III trialKelong Han, Jin Jin, Mauricio Maia, et al.
Japanese Journal of Ophthalmology|April 1, 2009
Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the Pan-American Collaborative Retina Study Group (PACORES) at the 12-month follow-upLihteh Wu, J Fernando Arevalo, Mauricio Maia, et al.
Bioanalysis|August 27, 2014
A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical studyKeyang Xu, Luna Liu, Mauricio Maia, et al.
Journal of Immunological Methods|May 18, 2018
Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serumJohn Lowe, Eric Wakshull, Theresa Shek, et al.
Toxicologic Pathology|December 10, 2020
Nonclinical Safety Assessment of FHTR2163, An Antigen-Binding Fragment Against HTRA1 for the Treatment of Geographic AtrophyEdward Dere, Susan Crowell, Mauricio Maia, et al.
Retinal Cases & Brief Reports|June 25, 2021
UNDERSTANDING THE MYSTERY MACULA, A SUPPLEMENT OF RETINAL CASES AND BRIEF REPORTSMauricio Maia, Raul N Vianna, Marcio B Nehemy, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
ReplyNadyr A Damasceno, Soraya A Horowitz, Mauricio Maia, et al.
Acta Ophthalmologica|November 13, 2007
Thermal damage to a light probe using a xenon light sourceFernando M Penha, Mauricio Maia, Michel E Farah, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 15, 2025
The use of amniotic membrane or inverted internal limiting membrane flap for large or refractory macular holes: a prospective, comparative study using microperimetryAnna Carolina Carvalho Araujo, Arnaldo F Bordon, Vinicius Falcão, et al.
Pageof 21